We found that the DNA base analogues described below can cause the same DNA cleavage as that induced by EU. Their synthetic schemes are shown following their respective synthetic procedures.
6-N-(3-propynyl)-5-methyl-2'-deoxycytidine (1)
Thymidine (1.21 g, 5.00 mmol) was suspended in CH 3 CN (20 mL). Triethylamine (5.58 mL, 40.0 mmol) and acetic anhydride (1.89 mL, 20.0 mmol) were added to the suspension. After stirring at 25°C for 21 hours, methanol (10 mL) was added to the solution and stirred for 2 hours. The solvent was removed by evaporation. AcOEt (100 mmL) and saturated NaClaq (100 mL) were added to the residue and the product was extracted to the organic layer. The organic layer was washed with saturated NaClaq (100 mL) twice, dried over magnesium sulfate, and filtered. The solvent was removed by evaporation and the residue was dried under reduced pressure. 1,2,4-triazole (3.45 g, 50 mmol), CH 3 CN (30 mL), and triethylamine (7.67 mL, 55.0 mmol) were added to the residue. POCl 3 (932 μL, 10.0 mmol) was slowly added to the solution under constant stirring. After stirring for 1 hour, the solvent was removed by evaporation. AcOEt (100 mmL) and saturated NaClaq (100 mL) were added to the residue and the product was extracted to the organic layer. The organic layer was washed with saturated NaClaq (100 mL) twice, dried over magnesium sulfate, and filtered. The solvent was removed by evaporation and the residue was dried under reduced pressure [20] . 1,4-dioxane (30 mL) was added to the residue and the solution was stirred.
Propargylamine (961 μL, 15.0 mmol) was added to the solution. After stirring at 25°C for 2 hours, methanol (30 mL) and 28% NH 3 aq (30 mL) were added to the solution. The solution was stirred at 25°C for 24 hours. The solvent was removed by evaporation and the product 1 was purified by silica gel column chromatography (10-15% MeOH/CH 2 Cl 2 ). The product 1 was obtained as a white powder (873 mg, 3.13 mmol, 63%): 4, 154.9, 138.0, 101.7, 87.2, 84.8, 81.5, 72.6, 70.4, 61.4, 40.3, 29.4, 13 
5'-O-dimetoxytrityl-6-N-(3-propynyl)-5-methyl-2'-deoxycytidine (2)
Pyridine (10 mL) was added to 1 (312 mg, 1.12 mmol) and DMTrCl (454 mg, 1.34 mmol). The solution was stirred at 25°C for 1 hour. After addition of methanol (10 mL), the solvent was removed by evaporation. The residual pyridine was removed by coevaporation with CH 2 Cl 2 and hexane. The product 2 was purified by silica gel column chromatography (2-5% MeOH, 2% Et 3 N/CH 2 Cl 2 ). The product 2 was obtained as a white powder (631 mg, 0.924 mmol, 83%): 1 H NMR (DMSO-d6) δ 7.63 (t, J = 5.7, 1H), 7.51 (s, 1H), 7. 39-7.35 (m, 2H),7.32-7.19 (m, 7H), 6.90-6.86 (m, 4H) ,6.21 (t, J = 6.6, 1H), 5.34 (d, J = 4.1, 1H), 4. 31-4.25 (m, 1H), 4.14-4.02 (m, 2H),3.90-3.86 (m, 1H),3.72 (s, 6H), 3.22-3.16 (m, 2H) ,3.09-3.00 (m, 6H),2.21-2.06 (m, 2H),1.50 (s, 3H), 1.23-1.15 (m, 9H); 13 C NMR (DMSO-d6) δ 162.3, 158.1, 157.9, 154.8, 144.7, 137.4, 135.5, 135.3, 130.0, 127.9, 127.7, 126.8, 113.2, 113.0, 101.9, 85.8, 85.4, 84.6, 81.4, 72.6, 70.5, 63.6, 55.0, 45.3, 29.4, 8.4 
Preparation of T 6 (C1)T 6
2 (291 mg, 0.426 mmol) was dissolved in CH 3 CN (5 mL). Disopropylethylamine (261 μL, 1.50 mmol) and 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (223 μL, 1.00 mmol) was added to the solution. The solution was stirred at 25°C for 30 minutes. AcOEt (25 mL) and saturated NaClaq (25 mL) were added to the suspension. The product was extracted to the organic layer. The organic layer was washed with saturated NaClaq (25 mL) twice, dried over magnesium sulfate, and filtered. The solvent was removed by evaporation and the residue was dried by coevaporation with acetonitrile and further dried under reduced pressure.
After dissolving the residue to CH 3 CN (10 mL), the phosphoramidite solution was used directly for automated DNA synthesis. T 6 (C1)T 6 was synthesized by standard phosphoramidite method on the DNA synthesizer. The protected oligonucleotide was cleaved by 28% NH 3 aq from the solid support and deprotected at 25°C for 16 hours in 28% NH 3 aq. After removal of ammonia by speed-vac, the aqueous solution was filtered through 0.45 μm filter. T 6 (C1)T 6 was purified by reversed-phase HPLC with a linear gradient over 20 minutes from 0 to 50% CH 3 CN/50 mM AF. The retention time of the product was 10.6 minutes. After the desalination, the product was identified by MALDI TOF mass 7, 157.4, 153.4, 145.3, 130.7, 128.6, 128.1, 123.2, 97.5, 91.6, 87.6, 85.8, 84.5, 69.7, 60.7, 54.9, 51.4, 45.4, 41.0, 30.4, 28.5, 19.6, 19.1, 13.5 
5'-O-dimethoxytrityl-4-N-[N,N-di(n-butyl)aminomethylene]-5-phenylethynyl -2'-deoxycytidine (4)
Pyridine (10 mL) was added to 3 (700 mg, 1.50 mmol) and DMTrCl (763 mg, 2.25 mmol). The solution was stirred at 25°C for 1 hour. After addition of methanol (10 mL), the solvent was removed by evaporation. The residual pyridine was removed by coevaporation with CH 2 Cl 2 and hexane. The product 4 was purified by silica gel column chromatography (0-5% MeOH, 2% Et 3 N/CH 2 Cl 2 ). The product 4 was obtained as white powder (924 7, 158.03, 158.01, 157.5, 153.4, 144.7, 144.3, 135.6, 135.4, 130.6, 129.7, 129.6, 128.3, 127.93, 127.86, 127.6, 126.6, 123.0, 113.2, 97.9, 91.7, 86.2, 85.9, 83.9, 70.6, 63.5, 54.9, 54.5, 45.4, 41.2, 30.4, 28.5, 19.6, 19.1, 13.5 
Preparation of T 6 (C2)T 6
4 (109 mg, 0.142 mmol) was dissolved in CH 3 CN (5 mL). Triethylamine (157 μL, 1.13 mmol) and 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (126 μL, 0.565 mmol) was added to the solution. The solution was stirred at 25°C for 30 minutes. AcOEt (25 mL) and saturated NaClaq (25 mL) were added to the suspension. The product was extracted to the organic layer. The organic layer was washed with saturated NaClaq (25 mL) twice, dried over magnesium sulfate, and filtered. The solvent was removed by evaporation and the residue was dried by coevaporation with acetonitrile and further dried under reduced pressure.
After dissolving the residue to CH 3 CN (4.7 mL), the phosphoramidite solution was used directly for automated DNA synthesis. T 6 (C2)T 6 was synthesized by the standard phosphoramidite method on the DNA synthesizer. The last DMTr group was not deprotected on the DNA synthesizer. The protected oligonucleotide was cleaved by 28% NH 3 aq from the solid support and deprotected at 25°C for 16 hours in 28% NH 3 aq. After removal of ammonia by speed-vac, the aqueous solution was filtered through a 0.45 μm filter.
5'-DMTr-T 6 (C2)T 6 was purified by reversed-phase HPLC with a linear gradient over 20 minutes from 5 to 50% CH 3 CN/50 mM AF. The retention time of the 5'-DMTr-T 6 (C2)T 6 was 15.2 minutes. After speed-vac and freeze-drying to remove the solvent and AF, the DMTr group was removed at 25°C for 30 minutes in 80% AcOHaq (100 μL). The solution was diluted with H 2 O to be ≈1 mL and passed through a 0.45 m filter. T 6 (C2)T 6 was purified by reversed-phase HPLC with a linear gradient over 20 minutes from 8 to 20% CH 3 CN/50 mM AF.
The retention time of the product was 13.6 minutes. After the desalination, the product was identified by MALDI TOF mass spectrometry: T 6 (C2)T 6 , calcd for 191.7, 156.2, 152.3, 149.6, 147.4, 135.4, 133.8, 131.5, 131.4, 130.8, 129.5, 119.3, 88.3, 85.7, 71.3, 62.2, 37.4 
6-N-[N,N-di(n-butyl)aminomethylene]-8-(2-formylphenyl)-2'-deoxyadenosin e (6)

(1.5g, 4.36 mmol) was dissolved in methanol (20 mL). N,N-di(n-butyl)-
formamide dimethyl acetal (8.14 mL, 34.8 mmol) was added to the solution [22] .
The solution was stirred at 25°C for 2 hours. The solvent was removed by evaporation. The product 6 was purified by silica gel column chromatography (2-5% MeOH/CH 2 Cl 2 ). The product 6 was obtained as a pale brown oil (1.40 g, 
5'-O-dimethoxytrityl-6-N-[N,N-di(n-butyl)aminomethylene]-8-(2-formylphen yl)-2'-deoxyadenosine (7)
Pyridine (10 mL) was added to 6 (1.31 g, 2.64 mmol) and DMTrCl (991 mg, 2.92 mmol). The solution was stirred at 25°C for 1 hour. After addition of methanol (10 mL), the solvent was removed by evaporation. The residual pyridine was removed by coevaporation with CH 2 Cl 2 and hexane. The product 7 was purified by silica gel column chromatography (2% MeOH, 2% Et 3 N/CH 2 Cl 2 ). The product 7 was obtained as a white powder (1.24 g, 1.56 mmol, 59%): 6, 159.2, 157.9, 157.9, 157.7, 151.8, 149.5, 145.0, 135.7, 135.60, 135.55, 133.6, 131.7, 131.4, 130.7, 129.7, 129.5, 129.1, 127.6, 126.5, 125.6, 113.0, 112.9, 85.8, 85.2, 84.8, 71.0, 63.6, 54.94, 54.90, 50.9, 44.4, 36.3, 30.4, 28.7, 19.6, 19.1, 13.7, 13.5 minutes. AcOEt (25 mL) and saturated NaClaq (25 mL) were added to the suspension. The product was extracted to the organic layer. The organic layer was washed with saturated NaClaq (25 mL) twice, dried over magnesium sulfate, and filtered. The solvent was removed by evaporation and the residue was dried by coevaporation with acetonitrile and further dried under reduced pressure.
After dissolving the residue in CH 3 CN (10 mL), the phosphoramidite solution was used directly for automated DNA synthesis. T 6 (A1)T 6 was synthesized by the standard phosphoramidite method on the DNA synthesizer. The last DMTr group was not deprotected on the DNA synthesizer. The protected oligonucleotide was cleaved from the solid support using 28% NH 3 aq and deprotected at 25°C for 16 hours in 28% NH 3 aq. After removal of ammonia by speed-vac, the aqueous solution was filtered through a 0.45 μm filter. 5'-DMTr-T 6 (C2)T 6 was purified by reversed-phase HPLC with a linear gradient over 20 minutes from 0 to 50% CH 3 CN/50 mM AF. The retention time of the 5'-DMTr-T 6 (A1)T 6 was 16.5 minutes.
After speed-vac and freeze-drying to remove the solvent and AF, the DMTr group was removed at 25°C for 30 minutes in 80% AcOHaq (100 μL). The solution was diluted with H 2 O to 1 mL and filtered through a 0.45 m filter. 156.5, 153.3, 151.8, 143.4, 135.5, 133.5, 132.5, 131.4, 130.1, 128.4, 117.5, 87.8, 84.6, 71.0, 61.9, 36.8; HRMS (ESI) 
2-N-[N,N-di(n-butyl)aminomethylene]-8-(2-formylphenyl)-2'-deoxyguanosin
e (9) 8 (2.32 g, 6.25 mmol) was dissolved in methanol (20 mL). N,N-di(n-butyl)-formamide dimethyl acetal (11.7 mL, 50.0 mmol) was added to the solution [22] .
The solution was stirred 25°C for 2 hours. The solvent was removed by evaporation. The product 9 was purified by silica gel column chromatography (5-10% MeOH/CH 2 Cl 2 ). The product 9 was obtained as a pale yellow powder (2.10 g, 4.11 mmol, 66%): 1 H NMR (DMSO-d6) δ 11.51 (s, 1H), 9.89 (s, 1H), 8.53 (s, 1H), 8.02-8.00 (m, 1H), 7.87-7.83 (m, 1H), 7.77-7.73 (m, 1H), 7.69-7.67 (m, 1H), 5.92 (dd, J = 7.8, 6.9, 1H), 5.16 (d, J = 4.2, 1H), 4.85-4.82 (m, 1H), 4.33-4.29 (m, 1H), 3.76-3.73 (m, 1H), 3.58-3.35 (m, 6H), 3.14 (ddd, J = 13.7, 7.3, 6.4, 1H), 2.05 (ddd, J = 13.3, 6.4, 2.8, 1H) 157.8, 157.4, 157.3, 150.5, 144.6, 135.5, 133.6, 132.1, 131.3, 130.2, 128.7, 120.5, 87.8, 85.0, 71.0, 62.0, 51.2, 44.9, 37.3, 30.3, 28.5, 19.6, 19.1, 13.7, 13.5; HRMS (ESI) 191.6, 158.0, 157.9, 157.5, 157.3, 156.9, 150.3, 144.9, 144.8, 135.7, 135.6, 133.4, 132.5, 131.2, 130.1, 129.6, 129.4, 128.3, 127.6, 126.5, 120.4, 112.9, 85.4, 85.2, 84.0, 70.6, 63.6, 55.0, 54.9, 51.2, 45.0, 37.6, 30.2, 28.5, 19.6, 19.0, 13.7, 13.5 minutes. AcOEt (25 mL) and saturated NaClaq (25 mL) were added to the suspension. The product was extracted to the organic layer. The organic layer was washed with saturated NaClaq (25 mL) twice, dried over magnesium sulfate, and filtered. The solvent was removed by evaporation and the residue was dried by coevaporation with acetonitrile and further dried under reduced pressure.
After dissolving the residue in CH 3 CN (10 mL), the phosphoramidite solution was used directly for automated DNA synthesis. T 6 (G1)T 6 was synthesized by standard phosphoramidite method on the DNA synthesizer. The last DMTr group was not deprotected on the DNA synthesizer. The protected oligonucleotide was cleaved by 28% NH 3 aq from the solid support and deprotected at 25°C for 16 hours in 28% NH 3 aq. After removal of ammonia by speed-vac, the aqueous solution was filtered through a 0.45 μm filter. 5'-DMTr-T 6 (G1)T 6 was purified by reversed-phase HPLC with a linear gradient over 20 minutes from 5 to 50% CH 3 CN/50 mM AF. The retention time of the 5'-DMTr-T 6 (G1)T 6 was 15.2 minutes. After speed-vac and freeze-drying to remove the solvent and AF, the DMTr group was removed at 25°C for 30 minutes in 80% AcOHaq (100 μL). The solution was diluted with H 2 O to 1 mL and filtered through 0.45 m filter. T 6 (C2)T 6 was purified by reversed-phase HPLC with a linear gradient over 20 minutes from 5 to 20% CH 3 CN/50 mM AF. The retention time of the product was 14.6 minutes. After desalination, the product was identified by MALDI TOF mass spectrometry: T 6 (G1)T 6 , calcd for C 137 
